GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (FRA:QS51) » Definitions » Quality Rank

Straumann Holding AG (FRA:QS51) Quality Rank


View and export this data going back to 2009. Start your Free Trial

What is Straumann Holding AG Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Straumann Holding AG Quality Rank Related Terms

Thank you for viewing the detailed overview of Straumann Holding AG's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Straumann Holding AG (FRA:QS51) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (FRA:QS51) » Definitions » Quality Rank
Comparable Companies
XSWX:ALC XSWX:YPSN XSWX:TECN XSWX:SKAN XSWX:CLTN XSWX:VBSN ISRG XPAR:EL BDX TSE:7741 OCSE:COLO B RMD WST XPAR:DIM TSE:4543 BAX COO HOLX TSE:7733 XTER:AFX
Traded in Other Exchanges
SAUHY:USA SAUHF:USA STMNz:UK 0QMV:UK STMN:Switzerland
Address
Peter Merian-Weg 12, Basel, CHE, 4002
Website
https://www.straumann-group.com
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly 30% of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.